ROLE OF IFNL4 GENOTYPE IN HEPATIC INFLAMMATION AMONG BLACK INDIVIDUALS WITH CHRONIC HEPATITIS C

被引：0
|
作者：
Gopalakrishna, Harish [1 ]
Pfeiffer, Ruth [2 ]
Ramelli, Sabrina C. [2 ]
Prokunina-Olsson, Ludmila [2 ]
Hewitt, Stephen M. [2 ]
Kleiner, David E. [3 ]
Ghany, Marc G. [1 ]
O'Brien, Thomas [2 ]
机构：
[1] NIDDK, NIH, Bethesda, MD 26506 USA
[2] NCI, Bethesda, MD 20892 USA
[3] NCI, Pathol Lab, Bethesda, MD 20892 USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2613-A
引用
收藏
页码：S1256 / S1256
页数：1
相关论文
共 50 条
  • [1] The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients
    Shridhar, R.
    Wimalanathan, T.
    Midgard, H.
    Ydreborg, M.
    Lagging, M.
    Moghaddam, A.
    Andersen, S. N.
    Dalgard, O.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S703 - S703
  • [2] The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients
    Gulati, Rachna Shridhar
    Wimalanathan, Thakshani
    Andersen, Solveig Norheim
    Isaksen, Kjetil
    Lagging, Martin
    Midgard, Havard
    Moghaddam, Amir
    Dalgard, Olav
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (09) : 1172 - 1175
  • [3] The role of IFNL4 in liver inflammation and progression of fibrosis
    Michelle Møhlenberg
    Thomas R. O’Brien
    Rune Hartmann
    Genes & Immunity, 2022, 23 : 111 - 117
  • [4] The role of IFNL4 in liver inflammation and progression of fibrosis
    Mohlenberg, Michelle
    O'Brien, Thomas R.
    Hartmann, Rune
    GENES AND IMMUNITY, 2022, 23 (3-4) : 111 - 117
  • [5] Treatment Response, IFNL3 (IL28B) and IFNL4 Genotype and Hepatic Expression of Interferons and Interferon-Stimulated Genes in Patients with Chronic Hepatitis C
    Noureddin, Mazen
    Rotman, Yaron
    Thomas, Emmanuel
    Zhang, Fang
    Park, Heiyoung
    Rehermann, Barbara
    Liang, T. Jake
    HEPATOLOGY, 2014, 60 : 1057A - 1057A
  • [6] IFNL4 polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients
    A. M. Kucherenko
    V. M. Pampukha
    K. Yu. Romanchuk
    S. Yu. Chernushyn
    I. A. Bobrova
    L. V. Moroz
    L. A. Livshits
    Cytology and Genetics, 2016, 50 : 330 - 333
  • [7] IFNL4 polymorphism as a predictor of chronic hepatitis C treatment efficiency in Ukrainian patients
    Kucherenko, A. M.
    Pampukha, V. M.
    Romanchuk, K. Yu.
    Chernushyn, S. Yu.
    Bobrova, I. A.
    Moroz, L. V.
    Livshits, L. A.
    CYTOLOGY AND GENETICS, 2016, 50 (05) : 330 - 333
  • [8] Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C
    Kraemer, Benjamin
    Nischalke, Hans Dieter
    Boesecke, Christoph
    Ingiliz, Patrick
    Voigt, Esther
    Mauss, Stefan
    Stellbrink, Hans-Juergen
    Baumgarten, Axel
    Rockstroh, Juergen K.
    Spengler, Ulrich
    Nattermann, Jacob
    AIDS, 2013, 27 (17) : 2817 - 2819
  • [9] Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C
    Aiken, Taylor
    Garber, Ari
    Thomas, Dawn
    Hamon, Nicole
    Lopez, Rocio
    Konjeti, Rajesh
    McCullough, Arthur
    Zein, Nizar
    Fung, John
    Askar, Medhat
    John, Binu V.
    PLOS ONE, 2016, 11 (11):
  • [10] IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis C
    Mori, Nami
    Imamura, Michio
    Kawakami, Yoshiiku
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Hayes, C. Nelson
    Aikata, Hiroshi
    Miki, Daiki
    Ochi, Hidenori
    Honda, Yohji
    Takaki, Shintaro
    Tsuji, Keiji
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2017, 47 (03) : E5 - E13
12345